drugset / Trial / NCT02603861

A Study of LY3154207 on Sleep in Healthy Male Participants

NCT02603861

Phase 1 Completed 16 enrolled Eli Lilly and Company
RandomizedCrossoverDouble-blindBasic science

Summary

This study will evaluate the effect of single doses of LY3154207 on the amount of time it takes for healthy sleep-deprived men to fall asleep. The study will also estimate how much LY3154207 gets into the blood stream and how long it takes the body to remove it. Information about any side effects that occur will be collected. Each participant will complete four study periods, which will last a total of about 8 weeks.

Timeline

Start
2015-11
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Mevidalen Small molecule Oral
Comparator Modafinil Small molecule 200 mg Oral

Indications

No indication recorded.